Viewing Study NCT02869256


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-29 @ 7:47 AM
Study NCT ID: NCT02869256
Status: UNKNOWN
Last Update Posted: 2017-11-21
First Post: 2016-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regional Central Database Recording of Chronic Myeloid Leukemia
Sponsor: Institut BergoniƩ
Organization:

Study Overview

Official Title: Regional Central Database Recording of Chronic Myeloid Leukemia
Status: UNKNOWN
Status Verified Date: 2017-11
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: LMC
Brief Summary: It will be a centralized database , multicentre (6 centers) , regional, chronic myelogenous leukemia cases of registration (CML) prospectively and retrospectively.
Detailed Description: Given the complexity and evolution of recommendations and to harmonize these, it appears necessary to establish a central database for recording , monitoring patients with CML supported by the participating centers the region and evaluation of care practices in use .

Indeed , the main purpose of this database is to provide diagnostic and therapeutic management of reported cases of chronic myeloid leukemia and to study the prognostic factors . The main objective is to improve significantly the percentage of patients treated adequately load in the region, in the initial stages of the disease and during its evolution.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: